Kingfisher Capital LLC Cuts Holdings in Humana Inc. (NYSE:HUM)

Kingfisher Capital LLC trimmed its holdings in shares of Humana Inc. (NYSE:HUM) by 1.9% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 4,906 shares of the insurance provider’s stock after selling 93 shares during the period. Kingfisher Capital LLC’s holdings in Humana were worth $1,833,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Pzena Investment Management LLC lifted its holdings in shares of Humana by 538.7% during the 2nd quarter. Pzena Investment Management LLC now owns 2,318,347 shares of the insurance provider’s stock valued at $866,250,000 after buying an additional 1,955,375 shares during the period. Davis Selected Advisers increased its stake in Humana by 16.1% in the 2nd quarter. Davis Selected Advisers now owns 2,311,362 shares of the insurance provider’s stock worth $863,640,000 after buying an additional 321,233 shares in the last quarter. Marshall Wace LLP increased its stake in Humana by 118.9% in the 2nd quarter. Marshall Wace LLP now owns 1,425,302 shares of the insurance provider’s stock worth $532,564,000 after buying an additional 774,085 shares in the last quarter. Sanders Capital LLC purchased a new position in shares of Humana during the fourth quarter valued at about $489,300,000. Finally, Ontario Teachers Pension Plan Board grew its position in shares of Humana by 11,647.2% during the first quarter. Ontario Teachers Pension Plan Board now owns 1,059,478 shares of the insurance provider’s stock valued at $367,342,000 after purchasing an additional 1,050,459 shares in the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research analysts recently commented on HUM shares. Oppenheimer lifted their price target on Humana from $370.00 to $400.00 and gave the stock an “outperform” rating in a research report on Thursday, August 1st. Deutsche Bank Aktiengesellschaft lifted their price target on Humana from $341.00 to $349.00 and gave the stock a “hold” rating in a research report on Friday, August 2nd. JPMorgan Chase & Co. upped their target price on Humana from $332.00 to $396.00 and gave the company a “neutral” rating in a research note on Wednesday, August 21st. Piper Sandler assumed coverage on Humana in a research note on Wednesday, June 26th. They set an “overweight” rating and a $392.00 target price on the stock. Finally, Baird R W raised Humana to a “hold” rating in a research note on Thursday, May 30th. Thirteen equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $398.70.

Humana Trading Down 0.2 %

HUM opened at $312.29 on Wednesday. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.66 and a quick ratio of 1.66. The company’s 50 day simple moving average is $354.61 and its two-hundred day simple moving average is $345.12. Humana Inc. has a 1-year low of $298.61 and a 1-year high of $530.54. The firm has a market capitalization of $37.60 billion, a price-to-earnings ratio of 19.45, a price-to-earnings-growth ratio of 2.44 and a beta of 0.50.

Humana (NYSE:HUM) last released its earnings results on Wednesday, July 31st. The insurance provider reported $6.96 earnings per share for the quarter, topping analysts’ consensus estimates of $5.89 by $1.07. The business had revenue of $29.54 billion for the quarter, compared to analyst estimates of $28.52 billion. Humana had a net margin of 1.53% and a return on equity of 16.12%. The business’s revenue was up 10.4% on a year-over-year basis. During the same period last year, the company posted $8.94 EPS. Analysts expect that Humana Inc. will post 16.01 EPS for the current fiscal year.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 25th. Stockholders of record on Monday, September 30th will be issued a dividend of $0.885 per share. The ex-dividend date of this dividend is Monday, September 30th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.13%. Humana’s dividend payout ratio is currently 22.04%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.